Pre-Test Putting it All Together in Bipolar Disorder: Newer/Novel Treatment Options in the Management of BD (Module 3) Pre-Test Which of the following statements regarding lumateperone is TRUE? In a 6-week trial, 0 patients experienced a ≥7% weight gain It directly activates NMDA and APV glutamatergic function It has a ~60x higher affinity for D2 receptors than 5-HT 2A It is indicated for the treatment of BD-I but not BD-II depression Unsure Please now rate your ability to use currently available therapies to manage bipolar disorder. Excellent Very Good Good Fair Poor
